Activation of endothelial roundabout receptor 4 reduces the severity of virus-induced keratitis

Journal of Immunology

Volumn 186, Issue 12, 2011, Pages 7195-7204

  Mulik, Sachin ^a   Sharma, Shalini ^a   Suryawanshi, Amol ^a   Veiga Parga, Tamara ^a   Reddy, Pradeep B J ^a   Rajasagi, Naveen K ^a   Rouse, Barry T ^a  

^a UNIVERSITY OF TENNESSEE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE DIPHOSPHATE RIBOSYLATION FACTOR 6; ENDOTHELIAL ROUNDABOUT RECEPTOR 4; LENTIVIRUS VECTOR; RAC1 PROTEIN; ROUNDABOUT RECEPTOR; SHORT HAIRPIN RNA; SLIT2 PROTEIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE SEVERITY; DRUG RECEPTOR BINDING; ENDOTHELIUM CELL; ENZYME INHIBITION; FEMALE; GENE SILENCING; HERPES SIMPLEX VIRUS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; VIRUS KERATITIS;

ANIMALS; EYE INFECTIONS; FEMALE; HERPES SIMPLEX; KERATITIS; MICE; NEOVASCULARIZATION, PATHOLOGIC; NERVE TISSUE PROTEINS; PROTECTIVE AGENTS; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIMPLEXVIRUS; UP-REGULATION;

EID: 79959540808     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1100014     Document Type: Article

References (35)

1. Streilein, J. W., M. R. Dana, and B. R. Ksander. 1997. Immunity causing blindness: five different paths to herpes stromal keratitis. Immunol. Today 18: 443-449.
2. Zhao, Z. S., F. Granucci, L. Yeh, P. A. Schaffer, and H. Cantor. 1998. Molecular mimicry by herpes simplex virus-type 1: autoimmune disease after viral infection. Science 279: 1344-1347. (Pubitemid 28119574)
3. Biswas, P. S., and B. T. Rouse. 2005. Early events in HSV keratitis - setting the stage for a blinding disease. Microbes Infect. 7: 799-810.
4. Deshpande, S. P., S. Lee, M. Zheng, B. Song, D. Knipe, J. A. Kapp, and B. T. Rouse. 2001. Herpes simplex virus-induced keratitis: evaluation of the role of molecular mimicry in lesion pathogenesis. J. Virol. 75: 3077-3088.
5. Russell, R. G., M. P. Nasisse, H. S. Larsen, and B. T. Rouse. 1984. Role of T-lymphocytes in the pathogenesis of herpetic stromal keratitis. Invest. Ophthalmol. Vis. Sci. 25: 938-944.
6. Kim, B., Q. Q. Tang, P. S. Biswas, J. Xu, R. M. Schiffelers, F. Y. Xie, A. M. Ansari, P. V. Scaria, M. C. Woodle, P. Lu, and B. T. Rouse. 2004. Inhibition of ocular angiogenesis by siRNA targeting vascular endothelial growth factor pathway genes: therapeutic strategy for herpetic stromal keratitis. Am. J. Pathol. 165: 2177-2185.
7. Zheng, M., M. A. Schwarz, S. J. Lee, U. Kumaraguru, and B. T. Rouse. 2001. Control of stromal keratitis by inhibition of neovascularization. Am. J. Pathol. 159: 1021-1029.
8. Gong, Y., and D. R. Koh. 2010. Neutrophils promote inflammatory angiogenesis via release of preformed VEGF in an in vivo corneal model. Cell Tissue Res. 339: 437-448.
9. Zheng, M., S. Deshpande, S. Lee, N. Ferrara, and B. T. Rouse. 2001. Contribution of vascular endothelial growth factor in the neovascularization process during the pathogenesis of herpetic stromal keratitis. J. Virol. 75: 9828-9835.
10. Nagy, J. A., A. M. Dvorak, and H. F. Dvorak. 2007. VEGF-A and the induction of pathological angiogenesis. Annu. Rev. Pathol. 2: 251-275.
11. Ferrara, N., H. P. Gerber, and J. LeCouter. 2003. The biology of VEGF and its receptors. Nat. Med. 9: 669-676.
12. Ambati, B. K., M. Nozaki, N. Singh, A. Takeda, P. D. Jani, T. Suthar, R. J. C. Albuquerque, E. Richter, E. Sakurai, M. T. Newcomb, et al. 2006. Corneal avascularity is due to soluble VEGF receptor-1. Nature 443: 993-997. (Pubitemid 44646176)
13. Ambati, B. K., E. Patterson, P. Jani, C. Jenkins, E. Higgins, N. Singh, T. Suthar, N. Vira, K. Smith, and R. Caldwell. 2007. Soluble vascular endothelial growth factor receptor-1 contributes to the corneal antiangiogenic barrier. Br. J. Ophthalmol. 91: 505-508.
14. Kendall, R. L., and K. A. Thomas. 1993. Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor. Proc. Natl. Acad. Sci. USA 90: 10705-10709.
15. Klinman, D. M., M. Zheng, M. Gierynska, and B. T. Rouse. 2002. DNA containing bioactive CpG motifs promote angiogenesis. Drug News Perspect. 15: 358-363.
16. Biswas, P. S., K. Banerjee, P. R. Kinchington, and B. T. Rouse. 2006. Involvement of IL-6 in the paracrine production of VEGF in ocular HSV-1 infection. Exp. Eye Res. 82: 46-54.
17. Suryawanshi, A., S. Mulik, S. Sharma, P. B. J. Reddy, S. Sehrawat, and B. T. Rouse. 2011. Ocular neovascularization caused by herpes simplex virus type 1 infection results from breakdown of binding between vascular endothelial growth factor A and its soluble receptor. J. Immunol. 186: 3653-3665.
18. Kim, B., S. Suvas, P. P. Sarangi, S. Lee, R. A. Reisfeld, and B. T. Rouse. 2006. Vascular endothelial growth factor receptor 2-based DNA immunization delays development of herpetic stromal keratitis by antiangiogenic effects. J. Immunol. 177: 4122-4131.
19. Jones, C. A., N. R. London, H. Chen, K. W. Park, D. Sauvaget, R. A. Stockton, J. D. Wythe, W. Suh, F. Larrieu-Lahargue, Y. S. Mukouyama, et al. 2008. Robo4 stabilizes the vascular network by inhibiting pathologic angiogenesis and endothelial hyperpermeability. Nat. Med. 14: 448-453.
20. Jones, C. A., N. Nishiya, N. R. London, W. Q. Zhu, L. K. Sorensen, A. C. Chan, C. J. Lim, H. Y. Chen, Q. S. Zhang, P. G. Schultz, et al. 2009. Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nat. Cell Biol. 11: 1325-1331.
21. Gröne, J., O. Doebler, C. Loddenkemper, B. Hotz, H. J. Buhr, and S. Bhargava. 2006. Robo1/Robo4: differential expression of angiogenic markers in colorectal cancer. Oncol. Rep. 15: 1437-1443.
22. London, N. R., W. Zhu, F. A. Bozza, M. C. Smith, D. M. Greif, L. K. Sorensen, L. Chen, Y. Kaminoh, A. C. Chan, S. F. Passi, et al. 2010. Targeting Robo4-dependent Slit signaling to survive the cytokine storm in sepsis and influenza. Sci. Transl. Med. 2: 23ra19.
23. Dana, M. R., S. N. Zhu, and J. Yamada. 1998. Topical modulation of interleukin-1 activity in corneal neovascularization. Cornea 17: 403-409. (Pubitemid 28307507)
24. Sharma, S., S. Mulik, N. Kumar, A. Suryawanshi, and B. T. Rouse. 2011. An anti inflammatory role of VEGFR2/src kinase inhibitor in HSV induced immunopathology. J. Virol. In press.
25. Park, K. W., C. M. Morrison, L. K. Sorensen, C. A. Jones, Y. Rao, C. B. Chien, J. Y. Wu, L. D. Urness, and D. Y. Li. 2003. Robo4 is a vascular-specific receptor that inhibits endothelial migration. Dev. Biol. 261: 251-267.
26. Nguyen Ba-Charvet, K. T., K. Brose, V. Marillat, T. Kidd, C. S. Goodman, M. Tessier-Lavigne, C. Sotelo, and A. Chédotal. 1999. Slit2-Mediated chemorepulsion and collapse of developing forebrain axons. Neuron 22: 463-473. (Pubitemid 29159846)
27. Yoon, K. C., J. A. Bae, H. J. Park, S. K. Im, H. J. Oh, X. H. Lin, M. Y. Kim, J. H. Lee, S. E. Lee, K. Y. Ahn, and K. K. Kim. 2009. Subconjunctival gene delivery of the transcription factor GA-binding protein delays corneal neovascularization in a mouse model. Gene Ther. 16: 973-981.
28. Lee, S., M. Zheng, B. Kim, and B. T. Rouse. 2002. Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus. J. Clin. Invest. 110: 1105-1111.
29. Finger, P. T. 2008. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int. J. Radiat. Oncol. Biol. Phys. 70: 974-977.
30. Avery, R. L., J. Pearlman, D. J. Pieramici, M. D. Rabena, A. A. Castellarin, M. A. Nasir, M. J. Giust, R. Wendel, and A. Patel. 2006. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology 113: 1695-1705, e1-e15.
31. Han, X., and M. C. Zhang. 2010. Potential anti-angiogenic role of Slit2 in corneal neovascularization. Exp. Eye Res. 90: 742-749.
32. Fenwick, M. L., and J. Clark. 1982. Early and delayed shut-off of host protein synthesis in cells infected with herpes simplex virus. J. Gen. Virol. 61(Pt l): 121-125.
33. Fenwick, M. L., and M. J. Walker. 1978. Suppression of the synthesis of cellular macromolecules by herpes simplex virus. J. Gen. Virol. 41: 37-51.
34. Kanangat, S., J. S. Babu, D. M. Knipe, and B. T. Rouse. 1996. HSV-1-mediated modulation of cytokine gene expression in a permissive cell line: selective upregulation of IL-6 gene expression. Virology 219: 295-300.
35. Kim, H. K., H. Zhang, H. Li, T. T. Wu, S. Swisher, D. He, L. Z. Wu, J. M. Xu, C. A. Elmets, M. Athar, et al. 2008. Slit2 inhibits growth and metastasis of fibrosarcoma and squamous cell carcinoma. Neoplasia 10: 1411-1420.